ADMA Biologics Inc — Quarterly Financial Data (NASDAQ:ADMA) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

Nouvelles

Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change

ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance

Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues

Le BPA de ADMA Biologics Inc a dépassé les attentes de 0,03$, le CA en dessous des prévisions

ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates

Résultats d’ADMA Biologics : l’élan peut-il égaler les objectifs élevés ?

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?

Adam Grossman, président d’Adma Biologics, vend pour 337.679$ d’actions

Adam Grossman, president of Adma Biologics, sells $337,679 in shares

Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer

NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note